Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs

被引:38
|
作者
Turapov, Obolbek [1 ]
O'Connor, Benjamin D. [1 ]
Sarybaeva, Asel A. [1 ]
Williams, Caroline [1 ]
Patel, Hemu [2 ]
Kadyrov, Abdullaat S. [3 ]
Sarybaev, Akpay S. [4 ]
Woltmann, Gerrit [5 ]
Barer, Michael R. [1 ,2 ]
Mukamolova, Galina V. [1 ]
机构
[1] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England
[2] Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Empath Pathol Serv, Leicester, Leics, England
[3] Natl Ctr Phthisiol, Bishkek, Kyrgyzstan
[4] Kyrgyz Indian Mt Biomed Res Ctr, Bishkek, Kyrgyzstan
[5] Glenfield Hosp, Dept Resp Med, Leicester, Leics, England
基金
英国生物技术与生命科学研究理事会;
关键词
RESUSCITATION-PROMOTING FACTORS; PULMONARY TUBERCULOSIS; ANTITUBERCULOSIS TREATMENT; SOLID CULTURE; IN-VIVO; GROWTH; CHEMOTHERAPY; MOXIFLOXACIN; BACILLI; RELAPSE;
D O I
10.1128/AAC.01380-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tuberculous sputum contains multiple Mycobacterium tuberculosis populations with different requirements for isolation in vitro. These include cells that form colonies on solid media (plateable M. tuberculosis), cells requiring standard liquid medium for growth (nonplateable M. tuberculosis), and cells requiring supplementation of liquid medium with culture supernatant (SN) for growth (SN-dependent M. tuberculosis). Here, we describe protocols for the cryopreservation and direct assessment of antimicrobial tolerance of these M. tuberculosis populations within sputum. Our results show that first-line drugs achieved only modest bactericidal effects on all three populations over 7 days (1 to 2.5 log(10) reductions), and SN-dependent M. tuberculosis was more tolerant to streptomycin and isoniazid than the plateable and nonplateable M. tuberculosis strains. Susceptibility of plateable M. tuberculosis to bactericidal drugs was significantly increased after passage in vitro; thus, tolerance observed in the sputum samples from the population groups was likely associated with mycobacterial adaptation to the host environment at some time prior to expectoration. Our findings support the use of a simple ex vivo system for testing drug efficacies against mycobacteria that have phenotypically adapted during tuberculosis infection.
引用
收藏
页码:2476 / 2483
页数:8
相关论文
共 50 条
  • [21] Toxicity of first-line drugs for treatment of tuberculosis in children: review
    Frydenberg, Alexis R.
    Graham, Stephen M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 (11) : 1329 - 1337
  • [22] Isoniazid-resistant tuberculosis treatment with first-line drugs
    Chien, Jung-Yien
    Wang, Jann-Yuan
    LANCET INFECTIOUS DISEASES, 2017, 17 (03): : 259 - 260
  • [23] Patient with allergy to first-line anti-tuberculosis drugs
    Larrea Urtaran, Xabier
    Dorda Benito, Anna
    Gratacos Santanach, Laura
    Nogue Pujadas, Elisabet
    Aguilar Salmeron, Raquel
    Salgado Serrano, Xavier
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2024, 37 (02) : 196 - 198
  • [24] Development of fluoroquinolones as first-line drugs for tuberculosis - at long last!
    O'Brien, RJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (11) : 1266 - 1268
  • [25] Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
    Allix-Beguec, Caroline
    Arandjelovic, Irena
    Bi, Lijun
    Beckert, Patrick
    Bonnet, Maryline
    Bradley, Phelim
    Cabibbe, Andrea M.
    Cancino-Munoz, Irving
    Caulfield, Mark J.
    Chaiprasert, Angkana
    Cirillo, Daniela M.
    Clifton, David
    Comas, Inaki
    Crook, Derrick W.
    De Filippo, Maria R.
    de Neeling, Han
    Diel, Roland
    Drobniewski, Francis A.
    Faksri, Kiatichai
    Farhat, Maha R.
    Fleming, Joy
    Fowler, Philip
    Fowler, Tom A.
    Gao, Qian
    Gardy, Jennifer
    Gascoyne-Binzi, Deborah
    Gibertoni-Cruz, Ana-Luiza
    Gil-Brusola, Ana
    Golubchik, Tanya
    Gonzalo, Ximena
    Grandjean, Louis
    He, Guangxue
    Guthrie, Jennifer L.
    Hoosdally, Sarah
    Hunt, Martin
    Iqbal, Zamin
    Ismail, Nazir
    Johnston, James
    Khanzada, Faisal M.
    Khor, Chiea C.
    Kohl, Thomas A.
    Kong, Clare
    Lipworth, Sam
    Liu, Qingyun
    Maphalala, Gugu
    Martinez, Elena
    Mathys, Vanessa
    Merker, Matthias
    Miotto, Paolo
    Mistry, Nerges
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1403 - 1415
  • [26] Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs
    Abate, G
    Miorner, H
    Ahmed, O
    Hoffner, SE
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (07) : 580 - 584
  • [27] Associations between Mycobacterium tuberculosis Beijing genotype and drug resistance to four first-line drugs: a survey in China
    Liu, Haican
    Zhang, Yuanyuan
    Liu, Zhiguang
    Liu, Jinghua
    Hauck, Yolande
    Liu, Jiao
    Dong, Haiyan
    Liu, Jie
    Zhao, Xiuqin
    Lu, Bing
    Jiang, Yi
    Vergnaud, Gilles
    Pourcel, Christine
    Wan, Kanglin
    FRONTIERS OF MEDICINE, 2018, 12 (01) : 92 - 97
  • [28] Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs:: Comparisons of the MGIT 960 and BACTEC 460 systems
    Huang, TS
    Tu, HZ
    Lee, SSJ
    Huang, WK
    Liu, YC
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2002, 32 (02): : 142 - 147
  • [29] Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis
    Idh, Jonna
    Mekonnen, Mekidim
    Abate, Ebba
    Wedajo, Wassihun
    Werngren, Jim
    Angeby, Kristian
    Lerm, Maria
    Elias, Daniel
    Sundqvist, Tommy
    Aseffa, Abraham
    Stendahl, Olle
    Schon, Thomas
    PLOS ONE, 2012, 7 (06):
  • [30] Associations between Mycobacterium tuberculosis Beijing genotype and drug resistance to four first-line drugs: a survey in China
    Haican Liu
    Yuanyuan Zhang
    Zhiguang Liu
    Jinghua Liu
    Yolande Hauck
    Jiao Liu
    Haiyan Dong
    Jie Liu
    Xiuqin Zhao
    Bing Lu
    Yi Jiang
    Gilles Vergnaud
    Christine Pourcel
    Kanglin Wan
    Frontiers of Medicine, 2018, 12 : 92 - 97